Document Detail

Activation of molecular oxygen by a metal-organic framework with open 2,2'-bipyridine for selective oxidation of saturated hydrocarbons.
MedLine Citation:
PMID:  23139936     Owner:  NLM     Status:  Publisher    
A metal-organic framework with open 2,2'-bipyridine sites can efficiently activate molecular oxygen for selective oxidation of a variety of saturated hydrocarbons with unprecedented activities and selectivities.
Jilan Long; Liming Wang; Xingfa Gao; Cuihua Bai; Huanfeng Jiang; Yingwei Li
Related Documents :
24423056 - Catalytic conversion of diazocarbonyl compounds to imines: applications to the synthesi...
23639526 - Laccase-mediated oxidation of small organics: bifunctional roles for versatile applicat...
11925236 - Aromatization of 1,6,7,7a-tetrahydro-2h-indol-2-ones by a novel process. preparation of...
25078096 - Synthesis of α,α-difluoromethylene alkynes by palladium-catalyzed gem-difluoroproparg...
18201686 - Structure-activity relationship of coumarin derivatives on xanthine oxidase-inhibiting ...
16439126 - Synthesis of alpha-substituted fosmidomycin analogues as highly potent plasmodium falci...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-8
Journal Detail:
Title:  Chemical communications (Cambridge, England)     Volume:  -     ISSN:  1364-548X     ISO Abbreviation:  Chem. Commun. (Camb.)     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-9     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9610838     Medline TA:  Chem Commun (Camb)     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
The Key Lab of Enhanced Heat Transfer and Energy Conservation, Ministry of Education, School of Chemistry and Chemical Engineering, South China University of Technology, Guangzhou 510640, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A multimodal, ?-amyloid-targeted contrast agent.
Next Document:  Veterans' Group Life Insurance (VGLI) no-health period extension. Final rule.